Detalhe da pesquisa
1.
Phase II Study of BEZ235 versus Everolimus in Patients with Mammalian Target of Rapamycin Inhibitor-Naïve Advanced Pancreatic Neuroendocrine Tumors.
Oncologist
; 23(7): 766-e90, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242283
2.
Pan-phosphatidylinositol 3-kinase inhibition with buparlisib in patients with relapsed or refractory non-Hodgkin lymphoma.
Haematologica
; 102(12): 2104-2112, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28971900